Oppenheimer analyst Michael Wiederhorn is updating its Amedisys (AMED) model following the Q4 earnings release. Amedisys is currently in the ...

Amedisys had a return on equity of 12.20% and a net margin of 3.57%. Sell-side analysts predict that Amedisys, Inc. will post 4.4 earnings per share for the current fiscal year. Amedisys Profile ...

Amedisys, for the fourth quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, ...

Mutual of America Capital Management LLC decreased its position in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by ...

Amedisys, for the fourth quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, Hospice and High Acuity Care. While the top- and bottom-line numbers ...

BATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported a fourth-quarter loss of $20.4 million, after reporting a profit in the same period a year earlier. On a ...

Amedisys (AMED) delivered earnings and revenue surprises of -8.57% and 0.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

(2) Adjusted EBITDA is defined as net (loss) income attributable to Amedisys, Inc. before net interest expense, provision for income taxes and depreciation and amortization, excluding certain ...

On Monday, Raymond James reaffirmed its Market Perform rating on Amedisys stock, following the company’s fourth-quarter financial results for 2024. Amedisys reported a revenue of $598.1 million ...

Truist Financial analyst David S Macdonald maintained a Hold rating on Amedisys (AMED – Research Report) today and set a price target of ...